Diabetes
Best Buy enters the CGM market with Dexcom G7 sensor as its first product
Best Buy is gearing up for the holiday season with an unexpected addition to its offerings: continuous glucose monitors (CGMs). ...
Dexcom CGMs Clinch Victories in Type 2 Diabetes and Pregnancy at EASD Conference
In the realm of continuous glucose monitors (CGMs), recent discussions have revolved around broadening their application beyond the traditional user ...
Abbott study shows FreeStyle Libre CGM and GLP-1 therapy improve diabetes outcomes
In the realm of diabetes management, a symbiotic relationship appears to be flourishing between Continuous Glucose Monitoring (CGM) technology and ...
Novo Nordisk partners with Aspen to boost insulin supply in Africa
Novo Nordisk, a prominent player in the diabetes pharmaceutical industry, is taking significant steps to bolster insulin supplies in Africa. ...
Abbott Partners With Bigfoot Biomedical To Integrate Diabetes Devices
Abbott has made a significant move by acquiring Bigfoot Biomedical, a diabetes management technology maker. While the financial terms of ...
Novo Nordisk Turns to Thermo Fisher for Production Aid with Obesity Drug Wegovy Amid Catalent Challenges
Novo Nordisk Struggles to Keep Up with High Demand for Wegovy, Enlists Thermo Fisher to Boost Production Amid soaring demand ...
Farxiga/Forxiga: Drug for Diabetes, Heart Failure and Kidney Disease
Farxiga is a brand name in the United States and Forxiga is the brand name in Europe and other countries. ...
Nine States Pushback Against Lilly’s $13.5M Insulin Pricing Settlement
In a dramatic legal showdown, nine states are raising objections to a potentially game-changing $13.5 million settlement that pharmaceutical giant ...
Novo Nordisk and Eli Lilly Ride Obesity and Diabetes Drugs to the Forefront in Q2 Pharmaceutical Performance
As the COVID-19 pandemic surged and waned, the biopharmaceutical industry witnessed a rollercoaster ride of revenue spikes and troughs. However, ...
TheracosBio’s Bold Move: New CEO Takes Charge After FDA Approval and Price Showdown with Diabetes Drug Brenzavvy
TheracosBio, after securing its first-ever FDA approval for the SGLT2 diabetes drug Brenzavvy, has undergone a CEO change, with Brian ...
Powerful Alliance: AstraZeneca Teams Up with SK Chemicals to Revolutionize Diabetes Treatment with Sidapvia Combo Drug
Korea’s SK Chemicals has recently entered into an agreement with AstraZeneca to manufacture the diabetes drug Sidapvia for the remainder ...
Better receives FDA approval for its primary DTx medication
Source –Better Therapeutics On 10 July, Digital health company Better Therapeutics received FDA approval for its lead digital therapeutic (DTx), ...
First cell treatment for type I diabetes is approved by the FDA
Source – FDA On June 29, 2023, CellTrans achieved a significant milestone by securing the first-ever FDA approval for a ...
National Institute for Health and Care Excellence remains skeptical about the effectiveness of Mounjaro for diabetes
Eli Lilly has received positive data for its experimental obesity therapies, but in the UK, it faced a setback as ...
A recent study demonstrates the efficacy of the digital Dario tool in managing severe diabetes
Source – DarioHealth A joint effort between DarioHealth and Sanofi has yielded promising results in a real-world study presented at ...
Pfizer Shares Progress of Clinical Development Program for GLP-1-RA in Adults with Obesity and Type II Diabetes Mellitus
Source – Pfizer On June 26, 2023, Pfizer Provides Update on Clinical Development Program for GLP-1-RA in Obesity and Type ...
Lilly’s SURMOUNT-2 Study Shows Tirzepatide Achieves Significant 15.7% Weight Reduction in Adults with Obesity and Type 2 Diabetes
Source – Eli Lilly On June 24, 2023, Eli Lilly and Company’s tirzepatide showed promising results in the SURMOUNT-2 Phase ...
Positive Phase IIIa Results: Once-Weekly Insulin Icodec Benefits Adults with Type 2 Diabetes
Source – Novo Nordisk Novo Nordisk, on June 25, 2023, released new findings from Phase IIIa trials, ONWARDS 1 and ...
EU Drug Regulator Scrutinizes Novo Nordisk and Eli Lilly Over GLP-1 Safety
The increased inspection of GLP-I therapies by the European Medicines Agency (EMA) has raised a warning about the possibility that ...
Lilly Launches “Tap the Cap” with Adam Duvall, the American Diabetes Association, and other partners
Source – Eli Lilly 20 June 2023, together with the American Diabetes Association (ADA) and professional baseball player Adam Duvall, ...
At the 83rd Scientific Sessions of the American Diabetes Association, Lilly will discuss fresh findings in the management of diabetes and obesity
Source – Eli Lilly On 20 June 2023 at the American Diabetes Association’s (ADA) 83rd Scientific Sessions in San Diego ...
